Pharmacological targeting of the autophagy pathway in pancreatic ductal adenocarcinoma cells
Pancreatic ductal adenocarcinoma (PDAC) is among the most devastating of all cancers. It is responsible for only 3% of cancer cases annually but is the cause of over 7% of cancer related deaths. Despite the prevalence of this diseases there remains a scarcity of rational targeted chemotherapies....
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/43515 |